semaglutide or tirzepatide. Weight loss: tirzepatide, which is better? Tirzepatide vs. Semaglutide: Which is

The most commonly reported adverse effects in Phase 2 trials were gastrointestinal in nature, including: Nausea (the most frequently reported) Vomiting Diarrhoea Constipation Decreased appetite These effects were generally dose-dependent and most pronounced during dose escalation, typically improving over time

In a published Phase 2 trial (48 weeks), adults with obesity who took retatrutide lost, on average, more weight at higher doses, with the 12 mg group showing 24.2% average weight change at 48 weeks (compared with 2.1% in the placebo group)

Constipation : To alleviate constipation, increase your fiber intake by eating fruits, vegetables, and whole grains

Research into microneedle patch technology is underway to deliver real GLP-1 medications, but its still in the initial phases